ViviCells International, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VCII research report →
About the company
ViviCells International, Inc. specializes in the preservation of stem cells. The company, which was established in 1995, adopted its current name in May 2008, having previously been known as Tropical Beverage Inc.
- CEO
- Kenneth S. Wulwick
- IPO
- 1998
- Employees
- 16
- HQ
- Evanston, IL, US
Price Chart
- Market Cap
- $11.39K
- P/E
- -2.19
- P/S
- 0.00
- P/B
- 0.02
- EV/EBITDA
- -16.07
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -0.73%
- ROIC
- -0.66%
- Revenue
- $0 · 0.00%
- Net Income
- $-5,189 · -225.94%
- EPS
- $0.00 · 100.00%
- Op Income
- $-5,190
- FCF YoY
- 0.00%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -2.92
- Avg Volume
- 226.64
Get TickerSpark's AI analysis on VCII
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our VCII coverage
Recent articles, reports, and earnings notes.
No research on VCII yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate VCII report →Similar companies
Peers in the same neighborhood.